Bilateral symmetric inflammatory reaction to hylan G-F 20 injection
نویسندگان
چکیده
منابع مشابه
Bilateral Hip Joint Hylan G-F 20 Granulomatous Synovitis due to Viscosupplementation Injections
We present the diagnosis of bilateral granulomatous inflammation of the hip joints associated with Hylan G-F 20 viscosupplementation injections. Clinicians recommending therapeutic Hylan injections for the management of hip arthritis should maintain clinical awareness regarding this potential complication.
متن کاملManaging joint pain in osteoarthritis: safety and efficacy of hylan G-F 20
The use of intra-articular viscosupplementation in the nonoperative management of patients with osteoarthritis has become quite popular. Recent clinical data have demonstrated that the anti-inflammatory and chondroprotective actions of hyaluronic acid viscosupplementation reduce pain while improving patient function. We review the basic science and development of viscosupplementation and discus...
متن کاملPreliminary Evaluation of Potential Disease Modification by Hylan G-F 20 (Synvisc®) Using dGEMRIC
INTRODUCTION Treatment of osteoarthritis (OA) continues to be primarily based on symptom modification. The concept of disease modification for OA has been proposed and potential drugs are in the pipeline. Hylan G-F 20 (Synvisc) is an FDA-approved hyaluronate derivative which is administered by injection into osteoarthritic joints for treating pain associated with osteoarthritis. The present stu...
متن کاملLong-Term (1-Year) Safety and Efficacy of a Single 6-mL Injection of Hylan G-F 20 in Indian Patients with Symptomatic Knee Osteoarthritis
INTRODUCTION The prevalence of symptomatic knee osteoarthritis (OA) among Asians ≥65 years is estimated to double by 2040. This study was designed to evaluate the safety and efficacy of a single, 6-mL intra-articular injection of hylan G-F 20 in Indian patients with knee OA at 26 weeks through to 52 weeks. METHODS This study was an open-label, multicentre, phase 4 clinical trial. Enrolled pat...
متن کاملHylan G-F 20: Review of its Safety and Efficacy in the Management of Joint Pain in Osteoarthritis
BACKGROUND Osteoarthritis (OA) is a chronic degenerative joint disease that is a clinically and economically important disease. The increased prevalence of OA with aging, coupled to the demographics of aging populations, make OA a high priority health care problem. Viscosupplementation (VS) is a well-established treatment option in knee OA that is included in the professional guidelines for tre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arthritis & Rheumatism
سال: 2001
ISSN: 0004-3591,1529-0131
DOI: 10.1002/1529-0131(200104)44:4<978::aid-anr156>3.0.co;2-n